Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Analysis of Long-term (Investment) Activity Ratios

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Long-term Activity Ratios (Summary)

Medtronic PLC, long-term (investment) activity ratios

Microsoft Excel
Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020
Net fixed asset turnover
Net fixed asset turnover (including operating lease, right-of-use asset)
Total asset turnover
Equity turnover

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24).


The analysis of the financial ratios over the periods from April 2020 to April 2025 reveals distinct trends in the utilization of assets and equity by the company.

Net Fixed Asset Turnover
This ratio exhibits a gradual decline from 5.99 in April 2020 to 4.91 in April 2025, indicating a decreasing efficiency in generating sales from net fixed assets over the years. The downward trend suggests either a relative increase in fixed asset base or a deceleration in sales attributable to fixed assets.
Net Fixed Asset Turnover (Including Operating Lease, Right-of-Use Asset)
Similarly, this ratio declines from 5.02 in April 2020 to 4.23 in April 2025. The inclusion of operating lease assets slightly lowers the turnover ratio compared to the net fixed asset turnover alone, with both metrics showing consistent decreasing patterns. This suggests that the company might be incorporating more leased assets which do not translate proportionally into revenue.
Total Asset Turnover
The total asset turnover ratio shows a modest overall increase from 0.32 in April 2020 and April 2021, rising to 0.37 by April 2025. This gradual improvement indicates enhanced efficiency in using all assets, not just fixed ones, to generate revenues over time, despite lower fixed asset turnover.
Equity Turnover
The equity turnover ratio demonstrates a positive and steady increase from 0.57 in April 2020 to 0.70 in April 2025. This trend reflects growing effectiveness in using shareholders’ equity to produce sales, which might be benefiting from either increased sales or optimized equity management.

Overall, while the fixed asset turnover ratios indicate a declining efficiency in using net fixed and leased assets, total asset turnover and equity turnover ratios show an improving trend. This mixture of patterns may imply that the company is balancing asset management by leveraging non-fixed assets or increasing operational efficiency in other asset categories, and improving equity utilization to sustain or grow sales performance.


Net Fixed Asset Turnover

Medtronic PLC, net fixed asset turnover calculation, comparison to benchmarks

Microsoft Excel
Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020
Selected Financial Data (US$ in millions)
Net sales
Property, plant, and equipment, net
Long-term Activity Ratio
Net fixed asset turnover1
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.
Net Fixed Asset Turnover, Sector
Health Care Equipment & Services
Net Fixed Asset Turnover, Industry
Health Care

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24).

1 2025 Calculation
Net fixed asset turnover = Net sales ÷ Property, plant, and equipment, net
= ÷ =

2 Click competitor name to see calculations.


The financial data reveals a consistent upward trend in net sales over the six-year period. Starting from US$28,913 million in 2020, net sales increased nearly every year, reaching US$33,537 million by 2025. This growth indicates steady revenue expansion.

Property, plant, and equipment (PP&E), net, also shows a clear increasing trend. The net value rose from US$4,828 million in 2020 to US$6,837 million in 2025. This suggests continuous investment in fixed assets and infrastructure.

Despite growth in both net sales and PP&E, the net fixed asset turnover ratio exhibits a downward trend during the same period. Beginning at 5.99 in 2020, the ratio steadily declined to 4.91 by 2025. This indicates that the company's sales relative to its fixed asset base are decreasing, signaling potentially lower efficiency in utilizing fixed assets to generate revenue.

Net Sales
Consistent growth from US$28,913 million to US$33,537 million over six years, reflecting steady revenue expansion.
Property, Plant, and Equipment, Net
Marked increase from US$4,828 million to US$6,837 million, indicating ongoing capital investment in physical assets.
Net Fixed Asset Turnover Ratio
Declined from 5.99 to 4.91, suggesting sales growth is not keeping pace proportionally with asset base expansion, potentially indicating reduced asset efficiency.

Overall, while sales and asset investments are growing, the diminishing fixed asset turnover ratio may warrant further examination of asset utilization strategies.


Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)

Medtronic PLC, net fixed asset turnover (including operating lease, right-of-use asset) calculation, comparison to benchmarks

Microsoft Excel
Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020
Selected Financial Data (US$ in millions)
Net sales
 
Property, plant, and equipment, net
Operating lease right-of-use assets (classified in Other assets)
Property, plant, and equipment, net (including operating lease, right-of-use asset)
Long-term Activity Ratio
Net fixed asset turnover (including operating lease, right-of-use asset)1
Benchmarks
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Competitors2
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Sector
Health Care Equipment & Services
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Industry
Health Care

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24).

1 2025 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset) = Net sales ÷ Property, plant, and equipment, net (including operating lease, right-of-use asset)
= ÷ =

2 Click competitor name to see calculations.


Net Sales
The net sales demonstrate a consistent upward trend over the six-year period, increasing from US$ 28,913 million in 2020 to US$ 33,537 million in 2025. Although there was a slight dip in 2023 compared to 2022, the overall trajectory shows steady growth in sales revenue.
Property, Plant, and Equipment, Net
The net value of property, plant, and equipment, including operating leases and right-of-use assets, exhibits a continuous increase from US$ 5,755 million in 2020 to US$ 7,937 million in 2025. This rise suggests ongoing investment in fixed assets or expansion of the asset base during the period analyzed.
Net Fixed Asset Turnover Ratio
The net fixed asset turnover ratio, which measures efficiency in using fixed assets to generate sales, reveals a declining pattern, moving from 5.02 in 2020 to 4.23 in 2025. This decline indicates that despite increasing sales and asset levels, the company’s effectiveness in utilizing fixed assets to produce revenue diminished over time.
Overall Insights
The concurrent increase in both net sales and fixed assets points to an expansion strategy; however, the decreasing fixed asset turnover ratio suggests that asset utilization efficiency may be weakening. This could imply that the growth in assets is outpacing sales gains, or that newer assets are not yet fully productive. Monitoring this trend will be important to address potential efficiency losses in the asset base.

Total Asset Turnover

Medtronic PLC, total asset turnover calculation, comparison to benchmarks

Microsoft Excel
Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020
Selected Financial Data (US$ in millions)
Net sales
Total assets
Long-term Activity Ratio
Total asset turnover1
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.
Total Asset Turnover, Sector
Health Care Equipment & Services
Total Asset Turnover, Industry
Health Care

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24).

1 2025 Calculation
Total asset turnover = Net sales ÷ Total assets
= ÷ =

2 Click competitor name to see calculations.


Net Sales
Net sales demonstrated a generally upward trend over the observed six-year period. Starting at 28,913 million USD in 2020, sales increased consistently almost every year, reaching 33,537 million USD by 2025. There was a slight decline in 2023 compared to 2022, but the trend resumed its positive trajectory thereafter.
Total Assets
Total assets fluctuated slightly throughout the period, beginning at 90,689 million USD in 2020 and peaking just above 93,000 million USD in 2021. Thereafter, assets showed a mild downward trend until 2024 before experiencing a modest increase in 2025, finishing at 91,680 million USD. Overall, total assets maintained a relatively stable level without significant growth or decline.
Total Asset Turnover
The total asset turnover ratio exhibited gradual improvement across the years, moving from 0.32 in 2020 to 0.37 in 2025. This indicates an enhanced efficiency in utilizing assets to generate sales, with a slight dip observed in 2023 that aligned with the slight decrease in net sales for that year.

Equity Turnover

Medtronic PLC, equity turnover calculation, comparison to benchmarks

Microsoft Excel
Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020
Selected Financial Data (US$ in millions)
Net sales
Shareholders’ equity
Long-term Activity Ratio
Equity turnover1
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.
Equity Turnover, Sector
Health Care Equipment & Services
Equity Turnover, Industry
Health Care

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24).

1 2025 Calculation
Equity turnover = Net sales ÷ Shareholders’ equity
= ÷ =

2 Click competitor name to see calculations.


The financial data reveals several notable trends over the examined periods.

Net sales
The net sales exhibit a generally upward trajectory throughout the years. Starting at 28,913 million US dollars in April 2020, this figure increases consistently to reach 33,537 million US dollars by April 2025. Although there is a slight dip observed in April 2023 compared to the previous year, the overall trend indicates steady growth in sales revenue.
Shareholders’ equity
Shareholders’ equity shows a declining pattern over the period. Beginning at 50,737 million US dollars in April 2020, the equity rises modestly until April 2022, peaking at 52,551 million US dollars. Subsequently, a downward trend emerges, with equity decreasing to 48,024 million US dollars by April 2025. This signals a reduction in net asset value available to shareholders in the most recent years.
Equity turnover
The equity turnover ratio steadily increases from 0.57 in April 2020 to 0.70 in April 2025. This suggests improving efficiency in utilizing the shareholders’ equity to generate sales revenue. The rise in this ratio, concurrent with the decrease in equity and increase in sales, reflects a more effective deployment of the company’s equity base over time.

In summary, the company demonstrates robust sales growth accompanied by declining shareholders’ equity, which enhances the equity turnover ratio. This combination points toward improved asset utilization but also suggests potential concerns regarding the reduction in equity value.